Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

AJVS. 2020; 66(2): 67-73


Clinical Observation on Three Nigerian Breeds of Sheep Experimentally Infected with Trypanosoma Vivax

Ibironke K. Oyewusi, Michael I. Takeet, Adewale O. Talabi, Adekayode O. Sonibare, Ebenezer B. Otesile.




Abstract

Livestock production has been continually challenged with trypanosomes of which Trypanosoma vivax is the most pathogenic cause and the least studied in sub-Saharan Africa. Five sheep of each of the three Nigerian breeds, viz: West African Dwarf (WAD), Yankassa and Ouda were intravenously infected with 2.5 × 106 Trypanosoma vivax per milliliter and monitored until the Packed Cell Volume (PCV) declined to 15% when they were treated with diminazene aceturate. Three animals of each breed served as the uninfected control. The parameters monitored were parasitemia, clinical signs, bodyweight, and PCV. Levels of parasitemia were not significantly different across the breeds. Thirteen out of fifteen infected sheep had fever three days pi, followed by signs of pale mucous membranes, enlarged lymph nodes, serous nasal discharge, loss of weight, and dullness at various days pi in all the infected sheep. There were no significant (p>0.05) differences between the weight of all infected animals in the three breeds. The mean PCV of infected sheep was significantly (P

Key words: Clinical observation, Sheep, Trypanosoma vivax






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.